Correction for Lack of Coincidence of Normal and Abnormal Calibration Slopes in ISI Determination

Summary

An underlying assumption of the WHO orthogonal regression model for prothrombin time standardisation is that a single line describes the relationship between PT of abnormal and normal plasmas. The aim was to evaluate Tomenson’s correction for lack of coincidence using the model of the ECAA human reagent with lyophilized plasma calibrations. Local ISI calibrations using ECAA lyophilized normal and abnormal plasmas were performed on coagulometers with the ECAA human thromboplastin. They gave a high incidence of non-linearity of the two calibration slopes. The mean percentage deviation from assigned values of the target coumarin plasmas coagulometer INR at 45 centres before local ISI correction was 16.6% and 11.9% respectively in two studies. After local ISI calibration, the unsigned deviation was reduced to 5.54% and 6.61% respectively. Tomenson’s correction for non-linearity further reduced the mean deviation to 3.08% and 2.96 % respectively in the two studies demonstrating the value of the procedure.

• References

• 1 WHO Expert Committee on Biological Standardisation 33rd Report, WHO Technical Series. 1983; 687:: 81-105.
• 2 Tomenson JA. A statistician’s independent evaluation. In van den Besselaar AMHP, Gralnick HR, Lewis SM. (eds) Thromboplastin calibration and oral anticoagulant control Martinus Nijhoff: The Hague; 1984. ch 5 87-108.
• 3 Hermans J, van den Besselaar AMHP, Loeliger EA, van der Velde EA. A collaborative calibration study of reference materials for thromboplastins. Thromb Haemost 1983; 50: 712-7.
• 4 Thomson JM, Tomenson JA, Poller L. The calibration of the second primary international reference preparation for thromboplastin (Thromboplastin, human, plain, coded BCT/253). Thromb Haemost 1984; 52: 336-42.
• 5 Thomson JM, Darby KV, Poller L. Calibration of BCT/441, the ICSH reference preparation for thromboplastin. Thromb Haemost 1986; 55: 379-82.
• 6 Tripodi A, Chantarangkul V, Braga M, Poller L, ten Cate JW, van den Besselaar AMHP, Mannucci PM. Results of a multicentre study assessing the status of a recombinant thromboplastin. Thromb Haemost 1994; 72: 261-7.
• 7 Poller L, Barrowcliffe TW, van den Besselaar AMHP, Jespersen J, Tripodi A, Houghton D. European Concerted Action on Anticoagulation (ECAA). The Multicentre Calibration of Rabbit and Human ECAA Reference Thromboplastins. Thromb Haemost 1996; 76: 977-82.
• 8 Tripodi A, Chantarangkul V, Negri B, Clerici M, Mannucci PM. International collaborative study for the calibration of a proposed reference preparation for thromboplastin, human recombinant, plain. Thromb Haemost 1998; 79: 439-43.
• 9 WHO Expert Committee on Biological Standardisation Requirements for thromboplastins and plasmas used to control oral anticoagulant therapy. 2 nd edition. 1999 (in press)
• 10 Poller L, van den Besselaar AMHP, Jespersen J, Tripodi A, Houghton D. The European Concerted Action on Anticoagulation (ECAA). Field studies of coagulometer effects on the ISI of ECAA thromboplastins. Thromb Haemost 1998; 80: 615-23.
• 11 van der Velde EA.. Orthogonal regression equation. In van den Besselaar AMHP, Gralnick HR, Lewis SM. (eds.) Thromboplastin calibration and oral anticoagulation Martinus Nijhoff; Boston: 1984: 25-40.